.png){kind=icon}
.png){kind=icon}
Return
Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency
.png){kind=icon}
OA
AI
DOI：10.1016/j.jlr.2022.100274.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Lipid accumulation in nonadipose tissues can cause lipotoxicity, leading to cell death and se- vere organ dysfunction. Adipose triglyceride lipase (ATGL) deficiency causes human neutral lipid stor- age disease and leads to cardiomyopathy; ATGL deficiency has no current treatment. One possible approach to alleviate this disorder has been to alter the diet and reduce the supply of dietary lipids and, hence, myocardial lipid uptake. However, in this study, when we supplied cardiac Atgl KO mice a low - or high-fat diet, we found that heart lipid accumula- tion, heart dysfunction, and death were not altered. We next deleted lipid uptake pathways in the ATGL- deficient mice through the generation of double KO mice also deficient in either cardiac lipoprotein lipase or cluster of differentiation 36, which is involved in an lipoprotein lipase-independent pathway for FA uptake in the heart. We show that neither deletion ameliorated ATGL-deficient heart dysfunction. Similarly, we determined that non-lipid-containing media did not prevent lipid accumulation by cultured myocytes; rather, the cells switched to increased de novo FA synthesis. Thus, we conclude that pathological storage of lipids in ATGL defi- ciency cannot be corrected by reducing heart lipid uptake.
Keywords:
CD36
dietary fat
lipid accumulation
lipotoxicity
storage diseases
LpL
lipid droplets
heart failure
myocardial lipid uptake
FA synthesis
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
4.1
Papers:
5.9K
Citations:
2.4W